Triumph Capital Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$712 Buy
2
+1
+100% +$322 ﹤0.01% 1745
2026
Q2
$483 Buy
+1
New +$265 ﹤0.01% 1734

Other funds holding ALAB

Triumph Capital Management's ALAB Position: Q3 2026 in Review

Triumph Capital Management increased its Astera Labs (ALAB) stake by 100% in Q3 2026, buying an estimated $322 and bringing the position to 2 shares worth $712. The position accounts for ﹤0.01% of the portfolio, ranked #1745.

Triumph Capital Management first reported a position in ALAB in Q2 2026 and has held it in 2 quarters since. 512 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • Triumph Capital Management held 2 shares of Astera Labs worth $712 as of Q3 2026.
  • Triumph Capital Management bought 1 Astera Labs share in Q3 2026, an estimated $322.
  • Astera Labs made up ﹤0.01% of Triumph Capital Management's portfolio in Q3 2026, its #1745 holding.
  • Triumph Capital Management first reported a position in Astera Labs in Q2 2026 and has held it in 2 quarters since.
  • 512 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Triumph Capital Management's 13F filing for Q3 2026, filed 14 Oct 2026.